39.98
price down icon1.21%   -0.49
after-market 시간 외 거래: 39.97 -0.010 -0.03%
loading
전일 마감가:
$40.47
열려 있는:
$40.54
하루 거래량:
611.64K
Relative Volume:
1.63
시가총액:
$3.05B
수익:
$13.17M
순이익/손실:
$-199.06M
주가수익비율:
-14.59
EPS:
-2.74
순현금흐름:
$-156.53M
1주 성능:
+0.08%
1개월 성능:
+1.99%
6개월 성능:
-7.30%
1년 성능:
-11.59%
1일 변동 폭
Value
$39.67
$41.40
1주일 범위
Value
$39.44
$41.40
52주 변동 폭
Value
$35.53
$50.99

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
명칭
Xenon Pharmaceuticals Inc
Name
전화
(604) 484-3300
Name
주소
200 - 3650 GILMORE WAY, BURNABY
Name
직원
259
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
XENE's Discussions on Twitter

XENE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XENE
Xenon Pharmaceuticals Inc
39.98 3.05B 13.17M -199.06M -156.53M -2.74
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-10 재개 Raymond James Outperform
2024-10-01 개시 H.C. Wainwright Buy
2024-01-04 개시 Citigroup Buy
2023-12-08 개시 Robert W. Baird Outperform
2023-10-24 재개 Cantor Fitzgerald Overweight
2023-04-25 개시 Cantor Fitzgerald Overweight
2022-12-14 개시 Goldman Buy
2022-12-12 개시 Cowen Outperform
2022-11-28 개시 Wells Fargo Overweight
2022-10-19 개시 Raymond James Outperform
2022-08-29 개시 BofA Securities Buy
2022-07-21 개시 JP Morgan Overweight
2021-10-28 개시 RBC Capital Mkts Outperform
2020-10-02 개시 SVB Leerink Outperform
2020-07-21 개시 Needham Buy
2020-06-01 재개 Jefferies Buy
2020-03-25 개시 Wedbush Outperform
2020-01-08 개시 William Blair Outperform
2019-09-20 개시 Guggenheim Buy
2018-08-08 재확인 Stifel Buy
2017-03-13 개시 Jefferies Buy
2016-10-21 개시 Stifel Buy
2016-09-26 개시 Guggenheim Buy
2016-04-14 재확인 Jefferies Buy
2015-10-30 재개 Jefferies Buy
2014-12-02 개시 Canaccord Genuity Buy
모두보기

Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스

pulisher
Feb 01, 2025

Leerink Partnrs Has Bearish Outlook for XENE FY2025 Earnings - MarketBeat

Feb 01, 2025
pulisher
Jan 29, 2025

Xenon Pharmaceuticals CEO sells shares worth $2.21 million - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Learn to Evaluate (XENE) using the Charts - Stock Traders Daily

Jan 29, 2025
pulisher
Jan 29, 2025

2,569 Shares in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Acquired by Avior Wealth Management LLC - Defense World

Jan 29, 2025
pulisher
Jan 27, 2025

Ian Mortimer Sells 22,468 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Q1 EPS Estimates for Xenon Pharmaceuticals Cut by Wedbush - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Wedbush Lowers Earnings Estimates for Xenon Pharmaceuticals - Defense World

Jan 27, 2025
pulisher
Jan 26, 2025

FY2029 Earnings Forecast for XENE Issued By Wedbush - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Predicts XENE FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Estimates XENE FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Traders Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Epidemic Keratoconjunctivitis Market Expected to Reach Huge - openPR

Jan 22, 2025
pulisher
Jan 19, 2025

Xenon Pharmaceuticals announces executive changes - MSN

Jan 19, 2025
pulisher
Jan 19, 2025

Assenagon Asset Management S.A. Has $9.35 Million Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jan 19, 2025
pulisher
Jan 19, 2025

Assenagon Asset Management S.A. Increases Stock Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Jan 19, 2025
pulisher
Jan 18, 2025

How To Trade (XENE) - Stock Traders Daily

Jan 18, 2025
pulisher
Jan 17, 2025

Xenon Pharmaceuticals’ CCO Departure and Consultancy Role - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Xenon Pharmaceuticals Inc. Announces Cessation of Christopher Von Seggern as Chief Commercial Office - Marketscreener.com

Jan 17, 2025
pulisher
Jan 17, 2025

Barclays PLC Increases Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jan 17, 2025
pulisher
Jan 17, 2025

Barclays PLC Acquires 13,903 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Rating of “Buy” from Brokerages - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalner's Epilepsy Potential - Seeking Alpha

Jan 16, 2025
pulisher
Jan 15, 2025

XENE Crosses Above Key Moving Average Level - Nasdaq

Jan 15, 2025
pulisher
Jan 13, 2025

Xenon Pharmaceuticals Inc (XENE-Q) QuotePress Release - The Globe and Mail

Jan 13, 2025
pulisher
Jan 13, 2025

Xenon Pharmaceuticals Sets Sights on Key 2025 Milestones - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Xenon Outlines Key Corporate Milestone Opportunities for 2025 - The Manila Times

Jan 13, 2025
pulisher
Jan 09, 2025

Traders Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

Investors Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

Trading (XENE) With Integrated Risk Controls - Stock Traders Daily

Jan 08, 2025
pulisher
Jan 07, 2025

Dravet Syndrome Thereapeutics Market Size, Future Consumer Behavior and Market Dynamics (2024-2034) - 100×100 Música

Jan 07, 2025
pulisher
Jan 07, 2025

Xenon to Showcase Innovations at J.P. Morgan Healthcare Conference - TipRanks

Jan 07, 2025
pulisher
Jan 07, 2025

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 07, 2025
pulisher
Jan 06, 2025

JPMorgan Chase & Co. Increases Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

JPMorgan Chase & Co. Buys 905,129 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jan 06, 2025
pulisher
Jan 05, 2025

hVIVO (LON:HVO) Stock Price Down 6.8% – Here’s What Happened - Defense World

Jan 05, 2025
pulisher
Jan 02, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Barclays PLC - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Barclays PLC Has $590,000 Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jan 02, 2025
pulisher
Dec 26, 2024

State Street Corp Buys 32,701 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

State Street Corp Boosts Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Xenon Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XENE) - Defense World

Dec 26, 2024
pulisher
Dec 25, 2024

Stifel Financial Corp Has $849,000 Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Dec 25, 2024
pulisher
Dec 22, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Dec 22, 2024
pulisher
Dec 22, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Dec 22, 2024
pulisher
Dec 20, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Franklin Resources Inc. - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) CFO Sherry Aulin Sells 18,709 Shares - MarketBeat

Dec 19, 2024

Xenon Pharmaceuticals Inc (XENE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
자본화:     |  볼륨(24시간):